Clinical Trial Update: Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

View source ↗

Summary

A USC-sponsored clinical trial evaluates a myeloid-derived suppressor cell assay in renal cell carcinoma; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Southern California | Conditions: Healthy Subject, Metastatic Renal Cell Cancer | Status: ACTIVE_NOT_RECRUITING